| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 10,337 | 6,147 | 12,226 | 10,657 | | Cost of Revenue | 7,179 | 5,254 | 9,160 | 8,001 | | | Gross Profit | 3,158 | 893 | 3,066 | 2,656 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,848 | 1,476 | 4,752 | 5,150 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 310 | (583) | (1,686) | (2,494) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (150) | (498) | (474) | (541) | | Earnings Before Interest And Taxes | 160 | (1,081) | (2,160) | (3,035) | | Interest Expense | 2,232 |
-
|
-
|
-
| | Income Before Tax | (2,072) | (1,081) | (2,160) | (3,035) | | Income Tax Expense | (812) | (381) | 5,959 | 15 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,260) | (700) | (8,119) | (3,050) | | | Non-recurring Events | | Discontinued Operations | (2,066) | (2,876) |
-
| (105) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,326) | (3,576) | (8,119) | (3,155) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (1,191) | | | Net Income Applicable To Common Shares | ($3,326) | ($3,576) | ($8,119) | ($4,346) |
|
0.47% Nasdaq 0.00%
Income Statement
